Glycogen Storage Disease Type II (GSD II) Completed Phase 2 Trials for Alglucosidase alfa (DB01272)

Back to Glycogen Storage Disease Type II (GSD II)

Also known as: Glycogen Storage Disease Type II GSD II / Glycogen Storage Disease Type II (GSD-II)

IndicationStatusPhase
DBCOND0041318 (Glycogen Storage Disease Type II (GSD II))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00765414Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies.Treatment
NCT00250939A Study of rhGAA in Patients With Late-Onset Pompe DiseaseTreatment